Artificial intelligence in engineering drug discovery
In an age where antimicrobial resistance looms large and traditional antibiotics falter against resistant microorganisms, the global battle against infectious diseases demands innovation. Enter artificial intelligence (AI) – a game-changer in drug delivery. Our review navigates through this cutting-...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Tagungsbericht |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | |
| container_title | |
| container_volume | 3188 |
| creator | Sheikh, Saif Bhange, Manjusha |
| description | In an age where antimicrobial resistance looms large and traditional antibiotics falter against resistant microorganisms, the global battle against infectious diseases demands innovation. Enter artificial intelligence (AI) – a game-changer in drug delivery. Our review navigates through this cutting-edge alliance, spotlighting AI’s role in optimizing infectious disease treatment. From drug development and precise dosing to novel delivery methods and outcome forecasting, we delve into AI’s potential and the hurdles it faces. Join us in uncovering how AI could reshape the future of drug delivery and infectious disease management. |
| doi_str_mv | 10.1063/5.0240448 |
| format | Conference Proceeding |
| fullrecord | <record><control><sourceid>proquest_scita</sourceid><recordid>TN_cdi_proquest_journals_3142698573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3142698573</sourcerecordid><originalsourceid>FETCH-LOGICAL-p638-7d815f92d2c435b9b0036c7d2cfccddff4ddc49ccb6a98b9184396a0153c66883</originalsourceid><addsrcrecordid>eNotkEtLw0AAhBdRMFYP_oOANyF1349jKVqFgpcevC2bfYQtcRN3E6H_3kh7mWHgYwYGgEcE1why8sLWEFNIqbwCFWIMNYIjfg0qCBVtMCVft-CulCOEWAkhK8A2eYoh2mj6OqbJ933sfLJ-CbVPXUze55i62uV5kVjs8Ovz6R7cBNMX_3DxFTi8vR62783-c_ex3eybkRPZCCcRCwo7bClhrWohJNyKJQZrnQuBOmepsrblRslWIUmJ4gYiRiznUpIVeDrXjnn4mX2Z9HGYc1oWNUEUcyWZIAv1fKaKjZOZ4pD0mOO3ySeNoP5_RTN9eYX8AYCOU6M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype><pqid>3142698573</pqid></control><display><type>conference_proceeding</type><title>Artificial intelligence in engineering drug discovery</title><source>AIP Journals Complete</source><creator>Sheikh, Saif ; Bhange, Manjusha</creator><contributor>Gawande, Snehal P. ; Rajguru, Vijaya S. ; Adhau, Sarala P.</contributor><creatorcontrib>Sheikh, Saif ; Bhange, Manjusha ; Gawande, Snehal P. ; Rajguru, Vijaya S. ; Adhau, Sarala P.</creatorcontrib><description>In an age where antimicrobial resistance looms large and traditional antibiotics falter against resistant microorganisms, the global battle against infectious diseases demands innovation. Enter artificial intelligence (AI) – a game-changer in drug delivery. Our review navigates through this cutting-edge alliance, spotlighting AI’s role in optimizing infectious disease treatment. From drug development and precise dosing to novel delivery methods and outcome forecasting, we delve into AI’s potential and the hurdles it faces. Join us in uncovering how AI could reshape the future of drug delivery and infectious disease management.</description><identifier>ISSN: 0094-243X</identifier><identifier>EISSN: 1551-7616</identifier><identifier>DOI: 10.1063/5.0240448</identifier><identifier>CODEN: APCPCS</identifier><language>eng</language><publisher>Melville: American Institute of Physics</publisher><subject>Artificial intelligence ; Infectious diseases</subject><ispartof>AIP conference proceedings, 2024, Vol.3188 (1)</ispartof><rights>Author(s)</rights><rights>2024 Author(s). Published under an exclusive license by AIP Publishing.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://pubs.aip.org/acp/article-lookup/doi/10.1063/5.0240448$$EHTML$$P50$$Gscitation$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,794,4512,23930,23931,25140,27924,27925,76384</link.rule.ids></links><search><contributor>Gawande, Snehal P.</contributor><contributor>Rajguru, Vijaya S.</contributor><contributor>Adhau, Sarala P.</contributor><creatorcontrib>Sheikh, Saif</creatorcontrib><creatorcontrib>Bhange, Manjusha</creatorcontrib><title>Artificial intelligence in engineering drug discovery</title><title>AIP conference proceedings</title><description>In an age where antimicrobial resistance looms large and traditional antibiotics falter against resistant microorganisms, the global battle against infectious diseases demands innovation. Enter artificial intelligence (AI) – a game-changer in drug delivery. Our review navigates through this cutting-edge alliance, spotlighting AI’s role in optimizing infectious disease treatment. From drug development and precise dosing to novel delivery methods and outcome forecasting, we delve into AI’s potential and the hurdles it faces. Join us in uncovering how AI could reshape the future of drug delivery and infectious disease management.</description><subject>Artificial intelligence</subject><subject>Infectious diseases</subject><issn>0094-243X</issn><issn>1551-7616</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2024</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNotkEtLw0AAhBdRMFYP_oOANyF1349jKVqFgpcevC2bfYQtcRN3E6H_3kh7mWHgYwYGgEcE1why8sLWEFNIqbwCFWIMNYIjfg0qCBVtMCVft-CulCOEWAkhK8A2eYoh2mj6OqbJ933sfLJ-CbVPXUze55i62uV5kVjs8Ovz6R7cBNMX_3DxFTi8vR62783-c_ex3eybkRPZCCcRCwo7bClhrWohJNyKJQZrnQuBOmepsrblRslWIUmJ4gYiRiznUpIVeDrXjnn4mX2Z9HGYc1oWNUEUcyWZIAv1fKaKjZOZ4pD0mOO3ySeNoP5_RTN9eYX8AYCOU6M</recordid><startdate>20241210</startdate><enddate>20241210</enddate><creator>Sheikh, Saif</creator><creator>Bhange, Manjusha</creator><general>American Institute of Physics</general><scope>8FD</scope><scope>H8D</scope><scope>L7M</scope></search><sort><creationdate>20241210</creationdate><title>Artificial intelligence in engineering drug discovery</title><author>Sheikh, Saif ; Bhange, Manjusha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p638-7d815f92d2c435b9b0036c7d2cfccddff4ddc49ccb6a98b9184396a0153c66883</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Artificial intelligence</topic><topic>Infectious diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheikh, Saif</creatorcontrib><creatorcontrib>Bhange, Manjusha</creatorcontrib><collection>Technology Research Database</collection><collection>Aerospace Database</collection><collection>Advanced Technologies Database with Aerospace</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheikh, Saif</au><au>Bhange, Manjusha</au><au>Gawande, Snehal P.</au><au>Rajguru, Vijaya S.</au><au>Adhau, Sarala P.</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>Artificial intelligence in engineering drug discovery</atitle><btitle>AIP conference proceedings</btitle><date>2024-12-10</date><risdate>2024</risdate><volume>3188</volume><issue>1</issue><issn>0094-243X</issn><eissn>1551-7616</eissn><coden>APCPCS</coden><abstract>In an age where antimicrobial resistance looms large and traditional antibiotics falter against resistant microorganisms, the global battle against infectious diseases demands innovation. Enter artificial intelligence (AI) – a game-changer in drug delivery. Our review navigates through this cutting-edge alliance, spotlighting AI’s role in optimizing infectious disease treatment. From drug development and precise dosing to novel delivery methods and outcome forecasting, we delve into AI’s potential and the hurdles it faces. Join us in uncovering how AI could reshape the future of drug delivery and infectious disease management.</abstract><cop>Melville</cop><pub>American Institute of Physics</pub><doi>10.1063/5.0240448</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0094-243X |
| ispartof | AIP conference proceedings, 2024, Vol.3188 (1) |
| issn | 0094-243X 1551-7616 |
| language | eng |
| recordid | cdi_proquest_journals_3142698573 |
| source | AIP Journals Complete |
| subjects | Artificial intelligence Infectious diseases |
| title | Artificial intelligence in engineering drug discovery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A38%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_scita&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=Artificial%20intelligence%20in%20engineering%20drug%20discovery&rft.btitle=AIP%20conference%20proceedings&rft.au=Sheikh,%20Saif&rft.date=2024-12-10&rft.volume=3188&rft.issue=1&rft.issn=0094-243X&rft.eissn=1551-7616&rft.coden=APCPCS&rft_id=info:doi/10.1063/5.0240448&rft_dat=%3Cproquest_scita%3E3142698573%3C/proquest_scita%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3142698573&rft_id=info:pmid/&rfr_iscdi=true |